Concepedia

Anne‐Marie Duliège

AD

33

Publications

2.8K

Citations

25

H-Index

1992

Active since

Affiliations

Affymax (United States)(Current)

Johns Hopkins University

King's College Hospital

Saint Louis University

National Institutes of Health

Anne‐Marie Duliège is an author at Affymax (United States) specializing in medicine, immunology, and hiv.

Top concepts

Publications per year

1992–2023

33

Publications

33

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials

James B. Bussel, Donald M. Arnold, Elliot Grossbard et al. · American Journal of Hematology · 2018 · 329 citations · Full text

, , +19

A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant

Robert F. Pass, Anne‐Marie Duliège, Suresh B. Boppana et al. · The Journal of Infectious Diseases · 1999 · 247 citations

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

Guido Ferrari, Will Humphrey, M. Juliana McElrath et al. · Proceedings of the National Academy of Sciences · 1997 · 227 citations

Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1<sub>Mn</sub>gp120, HIV‐1<sub>SF2</sub>Recombinant gp120, or Both Vaccines in Seronegative Adults

Mary Lou Clements‐Mann, Kent J. Weinhold, Thomas J. Matthews et al. · The Journal of Infectious Diseases · 1998 · 190 citations · Full text

, , +19

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers

Robert B. Belshe, Geoffrey J. Gorse, Mark J. Mulligan et al. · AIDS · 1998 · 171 citations

Rows per page

1–5 of 33